STERIS’ (TSE:STE – Free Report) – Atb Cap Markets boosted their FY2025 earnings per share estimates for shares of STERIS’ in a report released on Wednesday, March 12th. Atb Cap Markets analyst W. Syed now anticipates that the company will earn $0.59 per share for the year, up from their previous estimate of $0.43. Atb Cap Markets currently has a “Strong-Buy” rating on the stock. Atb Cap Markets also issued estimates for STERIS’’s Q4 2025 earnings at ($0.11) EPS and Q4 2026 earnings at ($0.09) EPS.
Separately, Cormark upgraded STERIS’ to a “moderate buy” rating in a research note on Monday, January 6th.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Read More
- Five stocks we like better than STERIS’
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Insider Trades May Not Tell You What You Think
- 3 Must-Own Stocks to Build Wealth This Decade
- Investing in Construction Stocks
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
